Literature DB >> 18038115

Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction.

Natale Daniele Brunetti1, Pier Luigi Pellegrino, Michele Correale, Luisa De Gennaro, Andrea Cuculo, Matteo Di Biase.   

Abstract

AIM: To investigate correlations between plasmatic concentrations of acute phase proteins (APPs) and left ventricular systolic function during the early phase of acute myocardial infarction.
METHODS: Plasmatic concentrations of alpha-1-anti-trypsin (A1AT), alpha 1 glyco-protein (A1GP), haptoglobin (HG), caeruloplasmin (CP) and C-reactive protein (CRP) were evaluated in 123 patients with ST elevation acute myocardial infarction (STEMI) within 12 h after onset of chest pain. Systolic function was assessed with bi-dimensional echography and incidence of in-hospital adverse events was compared to APPs levels.
RESULTS: A1AT, A1GP, HG and CP showed a statistically significant correlation with admission CRP concentrations (P < 0.001). Left ventricular ejection fraction inversely correlated with plasmatic concentrations of A1GP, A1AT, CP and HG. Incidence of acute heart failure correlated with values of APPs and, in a stepwise analysis, CP values were the most significant markers of acute heart failure.
CONCLUSIONS: Systolic dysfunction in STEMI patients seems to be associated with an inflammatory response featured by a rise in plasmatic concentration of APPs; increase in APPs concentrations seems to own a short-term prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038115     DOI: 10.1007/s11239-007-0088-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  39 in total

1.  Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke.

Authors:  G Engström; P Lind; B Hedblad; L Stavenow; L Janzon; F Lindgärde
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

3.  Soluble CD40 ligand in acute and chronic heart failure.

Authors:  Thor Ueland; Pål Aukrust; Arne Yndestad; Kari Otterdal; Stig S Frøland; Kenneth Dickstein; John Kjekshus; Lars Gullestad; Jan K Damås
Journal:  Eur Heart J       Date:  2005-02-16       Impact factor: 29.983

4.  Inflammation and long-term mortality in acute congestive heart failure.

Authors:  Christian Mueller; Kirsten Laule-Kilian; Andreas Christ; Hans Peter Brunner-La Rocca; André P Perruchoud
Journal:  Am Heart J       Date:  2006-04       Impact factor: 4.749

5.  C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.

Authors:  Natale Daniele Brunetti; Rossella Troccoli; Michele Correale; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  Int J Cardiol       Date:  2005-08-01       Impact factor: 4.164

6.  Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

Authors:  Mahmoud Suleiman; Doron Aronson; Rabea Asleh; Michael R Kapeliovich; Ariel Roguin; Simcha R Meisel; Michael Shochat; Abeer Sulieman; Shimon A Reisner; Walter Markiewicz; Haim Hammerman; Rachel Lotan; Nina S Levy; Andrew P Levy
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

7.  Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction.

Authors:  M Kaźmierczak; M Sobieska; K Wiktorowicz; H Wysocki
Journal:  Int J Cardiol       Date:  1995-05       Impact factor: 4.164

8.  Congestive heart failure in copper-deficient mice.

Authors:  Laila Elsherif; Raymond V Ortines; Jack T Saari; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2003-07

9.  C-reactive protein in acute myocardial infarction: association with heart failure.

Authors:  Giuseppe Berton; Rocco Cordiano; Rosa Palmieri; Sigismondo Pianca; Valeria Pagliara; Paolo Palatini
Journal:  Am Heart J       Date:  2003-06       Impact factor: 4.749

10.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  10 in total

1.  Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.

Authors:  W H Wilson Tang; Yuping Wu; Jaana Hartiala; Yiying Fan; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Paul L Fox; Hooman Allayee; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

2.  Urinary trypsin inhibitor attenuated inflammatory response of patients undergoing cardiopulmonary bypass by inducing activated Treg cells.

Authors:  Xing Hao; Junyan Han; Zhichen Xing; Yu Hao; Chunjing Jiang; Jianping Zhang; Jing Yang; Xiaotong Hou
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

3.  Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.

Authors:  Muhammad Hammadah; Yiying Fan; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-08-13       Impact factor: 5.712

4.  Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.

Authors:  David J Kennedy; Yiying Fan; Yuping Wu; Michael Pepoy; Stanley L Hazen; W H Wilson Tang
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

5.  Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events.

Authors:  Natale Daniele Brunetti; Irene Munno; Pier Luigi Pellegrino; Vincenzo Ruggero; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Erasmo Giulio Campanale; Matteo Di Biase
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

6.  Gi proteins mediate activation of the canonical hedgehog pathway in the myocardium.

Authors:  Christian J Carbe; Lan Cheng; Sankar Addya; Jessica I Gold; Erhe Gao; Walter J Koch; Natalia A Riobo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-09       Impact factor: 4.733

7.  Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.

Authors:  Razvan T Dadu; Rhiannon Dodge; Vijay Nambi; Salim S Virani; Ron C Hoogeveen; Nicholas L Smith; Fengju Chen; James S Pankow; Cameron Guild; W H Wilson Tang; Eric Boerwinkle; Stanley L Hazen; Christie M Ballantyne
Journal:  Circ Heart Fail       Date:  2013-07-16       Impact factor: 8.790

8.  Oxidative Stress in Peritoneal Dialysis Patients: Association with the Dialysis Adequacy and Technique Survival.

Authors:  Natalia Stepanova; Lesya Korol; Olena Burdeyna
Journal:  Indian J Nephrol       Date:  2019 Sep-Oct

Review 9.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

10.  Ceruloplasmin and Coronary Heart Disease-A Systematic Review.

Authors:  Antonio P Arenas de Larriva; Laura Limia-Pérez; Juan F Alcalá-Díaz; Alvaro Alonso; José López-Miranda; Javier Delgado-Lista
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.